The patient was at a facility in Minneola, Florida, while the surgeon operated remotely from another facility ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...

ASX-listed healthcare companies are advancing new approaches to prostate cancer, spanning imaging, targeted therapies and ...

"Windsor is lucky to have Dr. Abed. There's no doubt about that — he is a miracle worker." ...

A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT), a form of high-dose radiation delivered in just five sessions, after ...

Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...

Final 2025 CDC data show a record-low U.S. fertility rate of 53.2 and a 7% drop in teen births. What the numbers mean for maternity care access. Ric Flair Hospitalized Following Tampa Fall Hours After ...

The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...

First and only non-invasive, Medicare-covered at-home therapy for post-prostatectomy urinary incontinence— available over the counter NEWTOWN, Conn., March 31, 2026 /PRNewswire/ -- Elidah today ...

New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...